
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ADRP CRISPR/Cas9 KO Plasmid (h) | sc-400802 | 20 µg | $397.00 |
PLIN2 encodes adipose differentiation-related protein (ADRP), a lipid droplet coat protein that regulates neutral lipid storage and the dynamics of lipid droplet biogenesis, expansion, and turnover. ADRP coordinates interactions between lipid droplets and cellular membranes and influences metabolic processes including fatty acid handling, lipotoxic stress responses, and organelle crosstalk in hepatocytes, adipocytes, and macrophages. Through its role in intracellular lipid trafficking and storage, PLIN2 is commonly studied in the context of hepatic steatosis, obesity-associated metabolic dysfunction, and foam cell formation during atherogenesis. Altered PLIN2 expression is also investigated in cancers with lipid droplet–rich phenotypes, where lipid storage programs can support proliferation and oxidative stress adaptation.
ADRP CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PLIN2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PLIN2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PLIN2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ADRP protein expression.
This CRISPR knockout system enables efficient generation of PLIN2-deficient cell models for investigation of ADRP signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.